|
3258
|
anti-ganglioside AS
✉
|
|
Serum |
|
667 (27,8) |
–
|
82455-7
|
—
|
› |
|
3242
|
anti-MAG As
✉
Myeline geassocieerde glycoproteïne antistoffen
|
|
Serum |
|
873 (36,4) |
–
|
31023-5
|
—
|
› |
|
3235
|
2M Antibody
✉
Kauwspiermyositis
|
|
Serum |
|
332 (13,8) |
–
|
—
|
—
|
› |
|
3221
|
Acetylchol. rec. As dier
✉
Myasthenia gravis antistoffen
|
|
Serum |
|
395 (16,5) |
–
|
—
nmol/l |
—
|
› |
|
3216
|
Myocard (1/100)
✉
Anti-myocard antistoffen
|
|
Serum |
1x per 3-4 weken |
70 (2,9) |
–
|
30537-5
|
—
|
› |
|
3199
|
Anaplasma phagocyt.paard
✉
|
|
Serum |
Maandag t/m vrijdag |
153 (6,4) |
–
|
—
|
—
|
› |
|
3147
|
A.N.A. kat
✉
|
|
Serum |
|
141 (5,9) |
–
|
—
|
—
|
› |
|
3144
|
A.N.A. (hond)
✉
|
|
Serum |
1x per week |
|
–
|
—
|
—
|
› |
|
3142
|
Rheumafactor
✉
|
|
Serum |
|
172 (7,2) |
–
|
—
|
—
|
› |
|
3030
|
Orosomucoiden
✉
Alfa-1 zure glycoproteïne
|
|
Serum |
2x per week |
201 (8,4) |
–
|
2685-6
g/L |
—
|
› |
|
3008
|
Hemopexine
✉
|
|
Serum |
Tenminste 1x per week |
|
–
|
2403-4
g/l |
—
|
› |
|
3003
|
Complement C3d
✉
|
|
EDTA |
|
|
–
|
—
% |
—
|
› |
|
2902
|
Complement C2
✉
|
|
Serum |
1x per 2 weken |
663 (27,6) |
–
|
4484-2
mg/l |
—
|
› |
|
2875
|
Immunoelectroforese dier
Panel
|
|
Serum |
|
|
–
|
—
|
—
|
› |
|
2661
|
Galactose
Panel
|
|
|
|
|
–
|
—
|
—
|
› |
|
2655
|
alfa Galactosidase
✉
|
|
EDTA |
1x per week |
308 (12,9) |
–
|
1813-5
µmol/L/h |
—
|
› |
|
2642
|
Aminozuren kwantitatief
✉
|
|
Heparine (Lithium-heparinebuis) |
2x per week |
303 (12,6) |
–
|
1913-3
|
35083-5
|
› |
|
2592
|
anti-IA2 antilichamen
✉
|
|
Serum |
Maandelijks |
909 (37,9) |
–
|
31209-0
U/mL |
—
|
› |
|
2434
|
CK iso-enzymen
✉
|
|
Serum |
Maandelijks |
969 (40,4) |
–
|
14680-3
U/l |
—
|
› |
|
2413
|
Trypsin-like imm. kat
✉
TLI (kat)
|
|
Serum |
1x per 2 weken |
470 (19,6) |
–
|
—
µg/l |
—
|
› |
|
2295
|
Fam. hypercholesterolemie
✉
|
|
EDTA |
|
17 (0,7) |
–
|
—
|
—
|
› |
|
2293
|
Famil.hyperlipidemie DNA
✉
apoB DNA, Familiale hypercholesterolemie, FH DNA
|
|
EDTA |
1x per 3 maanden |
221 (9,2) |
–
|
—
|
—
|
› |
|
2292
|
Lange keten vetzuren
✉
|
|
Serum |
|
|
–
|
43677-4
|
—
|
› |
|
2169
|
IJzerprofiel
✉
IJzerprofiel
|
|
Serum |
2x per week |
|
–
|
—
|
—
|
› |
|
2154
|
Geïoniseerd Calcium
✉
Ca++
|
|
Speciale afname |
|
25 (1) |
–
|
—
mmol/l |
—
|
› |
|
2000
|
Dikdruppel controle
Panel
|
|
EDTA |
|
146 (6,1) |
–
|
—
|
—
|
› |
|
1960
|
PNH onderzoek
Panel
FLAER expressie, Immunofenotypering (paroxysmale nachtelijke hemoglobinurie)
|
|
EDTA |
|
71 (3) |
–
|
55164-8
|
—
|
› |
|
1779
|
Flowcytometrie ikv
✉
Immunofenotypering, Lymfocyten fenotypering
|
|
EDTA |
|
1 (0) |
–
|
—
|
—
|
› |
|
1770
|
Immunofenotypering
Panel
Lymfocyten fenotypering
|
|
EDTA |
|
75 (3,1) |
–
|
—
|
—
|
› |
|
1712
|
MPN panel (12 genen)
✉
|
|
EDTA |
1x per week |
|
–
|
—
|
—
|
› |
|
1684
|
Pyruvaatkinase in RBC
✉
Pyruvaatkinase intraerythrocytair
|
|
EDTA |
|
459 (19,1) |
–
|
32552-2
U/g Hb |
—
|
› |
|
1683
|
JAK2 V617F mutatie
✉
JAK2 mutatie, JAK2 mutation
|
|
EDTA |
1x per week |
424 (17,7) |
–
|
—
|
—
|
› |
|
1680
|
Gluc-6-fosf.DH in RBC
✉
G6PD intraerythrocytair, Glucose-6-fosfaat dehydrogenase intraerythrocytair
|
|
EDTA |
Tenminste 1x per week |
119 (4,9) |
–
|
2357-2
U/ml ery |
—
|
› |
|
1640
|
Elueren RBC antistof BTCA
Panel
Elueren erythrocyten antistoffen - BTCA
|
|
EDTA |
|
|
–
|
—
|
—
|
› |
|
1630
|
Identificatie BTCA
Panel
DAT, DCT, Directe Coombs - BTCA
|
|
EDTA |
|
47 (2) |
–
|
—
|
—
|
› |
|
1620
|
Erythrocyten antistoffen
Panel
Erythrocyten antistoffen - BTCA, Irreguliere antistoffen (identificatie), Rode bloedcel antistoffen - BTCA
|
|
Serum, EDTA |
|
124 (5,2) |
–
|
—
|
—
|
› |
|
1577
|
Na proefcapacitatie (AML)
Panel
Semen-onderzoek na proefcapacitatie
|
|
Sperma (Semen) |
|
199 (8,3) |
–
|
—
|
—
|
› |
|
1575
|
Voor capacitatie (AML)
Panel
Semen-onderzoek voor proefcapacitatie
|
|
Sperma (Semen) |
|
127 (5,3) |
–
|
—
|
—
|
› |
|
1556
|
Na vasectomie
Panel
Semen-onderzoek postvasectomie
|
|
Sperma (Semen) |
|
18 (0,8) |
–
|
—
|
—
|
› |
|
1555
|
Morfologie
Panel
|
|
Sperma (Semen) |
|
197 (8,2) |
–
|
9704-8
|
—
|
› |
|
1553
|
Vitaalkleuring
Panel
|
|
Sperma (Semen) |
|
8 (0,3) |
–
|
—
|
—
|
› |
|
1550
|
Fertiliteit
Panel
Fertiliteitsonderzoek, Semen-onderzoek, Telling-Motiliteit-Morfologie
|
|
Sperma (Semen) |
|
197 (8,2) |
–
|
—
|
—
|
› |
|
1518
|
Moleculaire bepaling RHCE
Panel
|
|
EDTA |
|
|
–
|
—
|
—
|
› |
|
1478
|
DNA-onderzoek Gent
Panel
|
|
Heparine (Lithium-heparinebuis) |
|
|
–
|
—
|
—
|
› |
|
1477
|
DNA onderzoek VUB
Panel
|
|
Heparine (Lithium-heparinebuis) |
|
522 (21,8) |
–
|
—
|
—
|
› |
|
1476
|
DNA onderzoek Leuven
Panel
|
|
Heparine (Lithium-heparinebuis) |
|
5 (0,2) |
–
|
—
|
—
|
› |
|
1475
|
DNA onderzoek A'pen
Panel
|
|
Heparine (Lithium-heparinebuis) |
|
6 (0,3) |
–
|
—
|
—
|
› |
|
1459
|
HLA-DQB1/DRB1 (narcolep)
✉
|
|
EDTA |
1x per 2 weken |
|
–
|
—
|
—
|
› |
|
1451
|
Fragile X syndroom
✉
FMR1, Fragile X Mental Retardation 1-gen
|
|
EDTA |
|
|
–
|
—
|
—
|
› |
|
1449
|
Mucoviscidose
✉
CF, CFTR, Cystic Fibrosis Transmembrane conductance Regulator-gen
|
|
EDTA |
|
724 (30,1) |
–
|
—
|
—
|
› |
